The British Society of Gastroenterology 2025 Guidelines provide a comprehensive roadmap for both medical and surgical management.
The latest clinical guidelines for (Maladies Inflammatoires Chroniques de l'Intestin), specifically Crohn's Disease (MC) and Ulcerative Colitis (RCH), focus on early intervention, "treat-to-target" strategies, and the integration of new-generation biological therapies like Skyrizi . Key Updates in MICI Management (2024–2026) Download Nouvelles recommandations dans les MICI pdf
Provides patient-centered updates and the AFAMAG 2025 Management Report (PDF) which discusses emerging "combiotherapy" strategies. Newer agents such as IL-23 antagonists (e
Newer agents such as IL-23 antagonists (e.g., Skyrizi) and JAK inhibitors have been integrated into the 2025 treatment algorithms. you can access the following resources:
Offers detailed clinical practice guidelines for Crohn's Disease , including the French Recommendations for Crohn's Practice (PDF) .
For the most authoritative and up-to-date protocols, you can access the following resources: